Skip to content

A clinical trial to study the efficacy of Panchakarma Ayurveda management in Type 2 Diabetes patients.

Efficacy of Vamana, Virechana and Basti followed by Shamana in the Management of Sthula Pramehi w.s.r. to Type 2 Diabetes - An Open Labelled Randomized Standard Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025922
Enrollment
30
Registered
2020-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: GROUP-A: Deepana, Pachana with Sunthi and Haritaki 6gm BD for 5days Snehapana with Triphala sidh Sarshapa Taila dose as per agni and kostha for 3to7 days Abhyanga and MraduVashpa Sweda

Sponsors

IPGT AND RA GAU Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient having classical signs and symptoms of the disease. 2)Patients of having BMI >25 ââ?¬â?? 35 kg/m2 3)Patient of Type 2 Diabetes with blood sugar level, FBS - 126 to 300 mg/dl or PPBS - 200 to 350 mg/dl or HbA1C% - ââ?°Â¥6.5% To 12% 4)Age group of 20-60 years. 5)Patient fit for Vamana and Virechana and Basti Karma.

Exclusion criteria

Exclusion criteria: 1)Age 60 yrs. 2)Patients of Type-2 Diabetes having BMI 35 kg/m2 and Disease Chronicity > 10yrs. 3)Patients of Type-1 Diabetes or the patients of Type-2 Diabetes taking Insulin. 4)Patients having complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot, Carbuncles etc. 5)Patients having Diabetes in association with other endocrinopathies like Pheochromocytoma, Acromegaly, Cushingââ?¬•s syndrome, hyperthyroidism etc. 6)Patients having drug or chemical induced Type 2 Diabetes, like glucocorticoids induced or thyroid hormone induced etc. 7)Patients with genetic syndromes associated with Type 2 Diabetes like Downââ?¬•s Syndrome, Klinefelterââ?¬•s Syndrome, Turnerââ?¬•s syndrome etc. 8)Patients complicated with any cardiovascular diseases, renal diseases, Carcinoma or any other disease effecting multiple body systems and pregnant women etc. 9)Patient not fit for Vamana and Virechana and Basti Karma.

Design outcomes

Primary

MeasureTime frame
Changes in FBS,PPBS and BMITimepoint: 3rd-5th-7th-10th week

Secondary

MeasureTime frame
Improvement in signs & symptoms of Type 2 diabetesTimepoint: 3rd-5th-7th-10th week

Countries

India

Contacts

Public ContactProf Dr Anup B Thakar

IPGT and RA GAU Jamnagar

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026